Palantir’s Meteoric Rise in 2024 Palantir Technologies has emerged as the top-performing stock in the S&P 500 for…
This article Palantir: The S&P 500’s Top Gainer of the Year – Can the Momentum Continue? 🏄♂️ appeared first on Guerilla Stock Trading.
Cryptocurrencies have taken the world by storm over the past decade, transforming the way we think about money, investments, and financial technology. As someone who has recently ventured into the world of crypto, you might be wondering how to navigate this complex yet promising landscape, especially within Singapore—a country known for its proactive approach to…
SYDNEY — Australian fast-food chain Guzman y Gomez plans to go public on the Australian Securities Exchange on June 20, the company announced on Friday, looking at a valuation of around 2.2 billion Australian dollars ($1.5 billion). The company expects AU$242.5 million to be raised from the initial public offering. The listing includes AU$200 million…
Overall Analysis Gold breaks the long-term supporting trendline and sustains below it. Previous buying swings are still intact. Silver fell sharply on 6th Nov trading session, currently moving sideways, trying to hold level. Gold Chart Analysis Gold/USD 15-Minute Chart (Source: TradingView) On the 6th Nov 2024 trading session, gold broke the major supporting trendline and…
Microblog: WATCH OUT! “DeathPattern” Flashes Most Dire Warning in Decades | Stock Gumshoe Skip to Main Content What is the information being pitched by Jim Rickards of the Paradiem Press warning about a 100% Guarantee of an upcoming Stock Market Crash? This is a discussion topic or guest posting submitted by a Stock Gumshoe reader….
“No man is an island” — John Donne I’m about to release a new investment thesis that will define my stock investing for the next 2-3 years. I intended to drop this research on you today. But we’re still putting the finishing touches on it. So I can now confirm it will be hitting your…
Cullen Frost Bankers Inc. grew its stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 51.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 94,027 shares of the medical instruments supplier’s stock after a Source link